Practical coagulation for the blood banker

Transfusion

Volumn 53, Issue 7, 2013, Pages 1594-1602

  Hoffman, Maureane ^a   Cichon, Lisa J H ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 8; DABIGATRAN ETEXILATE; FRESH FROZEN PLASMA; LOW MOLECULAR WEIGHT HEPARIN; PROTHROMBIN COMPLEX; RIVAROXABAN; THROMBIN; THROMBOPLASTIN; VITAMIN K GROUP; VON WILLEBRAND FACTOR; WARFARIN;

ALLERGIC REACTION; ANTICOAGULATION; BLEEDING TENDENCY; BLOOD BANK; BLOOD CLOTTING; BLOOD CLOTTING TEST; BLOOD CLOTTING TIME; BLOOD COMPONENT; BLOOD TRANSFUSION; BLOOD VESSEL WALL; CELL SURFACE; CEREBROVASCULAR ACCIDENT; CLINICAL LABORATORY; COHORT ANALYSIS; DEEP VEIN THROMBOSIS; EMERGENCY WARD; ENZYME ACTIVITY; FAMILY HISTORY; FIBRIN POLYMERIZATION; GENERAL HOSPITAL; HEAD INJURY; HEALTH CARE PERSONNEL; HEART ATRIUM FIBRILLATION; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HUMAN; IN VIVO STUDY; INTERNATIONAL NORMALIZED RATIO; INVASIVE PROCEDURE; KNEE ARTHROPLASTY; LUNG EMBOLISM; MEDICAL SPECIALIST; PARTIAL THROMBOPLASTIN TIME; PATIENT CARE; PHOSPHOLIPID VESICLE; PLASMA TRANSFUSION; PROSPECTIVE STUDY; PROTHROMBIN TIME; REVIEW; SCREENING TEST; SUBDURAL HEMATOMA; TRANSFUSION RELATED ACUTE LUNG INJURY; UNITED STATES; VASOCONSTRICTION;

ADULT; AGED; ANTICOAGULANTS; BLOOD BANKS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; FEMALE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; THROMBIN;

EID: 84880216417     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12201     Document Type: Review

References (47)

1. Morawitz P,. The chemistry of blood coagulation. Springfield (IL): Charles C. Thomas; 1958.
2. Patek A, Taylor F,. Hemophilia II. Some properties of a substance obtained from normal human plasma effective in accelerating the coagulation of hemophilic blood. J Clin Invest 1937; 16: 113-124.
3. Brinkhous K,. A study of the clotting defect in hemophilia: the delayed formation of thrombin. Am J Med Sci 1939; 198: 509-516.
4. Hougie C,. The waterfall-cascade and autoprothrombin hypotheses of blood coagulation: personal reflections from an observer. J Thromb Haemost 2004; 2: 1225-1233.
5. MacFarlane RG,. An enzyme cascade in the blood clotting mechanism, and its function as a biological amplifier. Nature 1964; 202: 498-499.
6. Davie EW, Ratnoff OD,. Waterfall sequence for intrinsic blood clotting. Science 1964; 145: 1310-1312.
7. Østerud B, Rapaport SI,. Activation of factor IX by the reaction product of tissue factor and factor VII: additional pathway for initiating blood coagulation. Proc Natl Acad Sci U S A 1977; 74: 5260-5264.
8. Nemerson Y, Esnouf MP,. Activation of a proteolytic system by a membrane lipoprotein: mechanism of action of tissue factor. Proc Natl Acad Sci U S A 1973; 70: 310-314.
9. Nemerson Y,. The tissue factor pathway of blood coagulation. Semin Hematol 1992; 29: 170-176.
10. Gailani D, Broze GJ Jr,. Factor XI activation in a revised model of blood coagulation. Science 1991; 253: 909-912.
11. Hoffman M, Monroe DM 3rd,. A cell-based model of hemostasis. Thromb Haemost 2001; 85: 958-965.
12. Hoffman M, Monroe DM, Oliver JA, Roberts HR,. Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood 1995; 86: 1794-1801.
13. Rawala-Sheikh R, Ahmad SS, Monroe DM, Roberts HR, Walsh PN,. Role of gamma-carboxyglutamic acid residues in the binding of factor IXa to platelets and in factor-X activation. Blood 1992; 79: 398-405.
14. Le D, Borgs P, Toneff T, Witte M, Rapaport S,. Hemostatic factors in rabbit limb lymph: relationship to mechanisms regulating extravascular coagulation. Am J Physiol 1998; 274: H769-776.
15. Hoffman M, Colina CM, McDonald AG, Arepally GM, Pedersen L, Monroe DM,. Tissue factor around dermal vessels has bound factor VII in the absence of injury. J Thromb Haemost 2007; 5: 1403-1408.
16. Alberio L, Safa O, Clemetson KJ, Esmon CT, Dale GL,. Surface expression and functional characterization of alpha-granule factor V in human platelets: effects of ionophore A23187, thrombin, collagen, and convulxin. Blood 2000; 95: 1694-1702.
17. Dale GL, Friese P, Batar P, Hamilton SF, Reed GL, Jackson KW, Clemetson KJ, Alberio L,. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature 2002; 415: 175-179.
18. Kempton CL, Hoffman M, Roberts HR, Monroe DM,. Platelet heterogeneity: variation in coagulation complexes on platelet subpopulations. Arterioscler Thromb Vasc Biol 2005; 25: 861-866.
19. Monroe DM, Hoffman M, Roberts HR,. Transmission of a procoagulant signal from tissue factor-bearing cell to platelets. Blood Coagul Fibrinolysis 1996; 7: 459-464.
20. Oliver J, Monroe D, Roberts H, Hoffman M,. Thrombin activates factor XI on activated platelets in the absence of factor XII. Arterioscler Thromb Vasc Biol 1999; 19: 170-177.
21. Monroe DM, Roberts HR, Hoffman M,. Platelet procoagulant complex assembly in a tissue factor-initiated system. Br J Haematol 1994; 88: 364-371.
22. Baglia FA, Walsh PN,. Prothrombin is a cofactor for the binding of factor XI to the platelet surface and for platelet-mediated factor XI activation by thrombin. Biochemistry 1998; 37: 2271-2281.
23. Lorand L,. Factor XIII: structure, activation, and interactions with fibrinogen and fibrin. Ann N Y Acad Sci 2001; 936: 291-311.
24. Bajzar L, Manuel R, Nesheim ME,. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 1995; 270: 14477-14484.
25. Ofosu FA,. Protease activated receptors 1 and 4 govern the responses of human platelets to thrombin. Transfus Apher Sci 2003; 28: 265-268.
26. Mann KG, Brummel K, Butenas S,. What is all that thrombin for? J Thromb Haemost 2003; 1: 1504-1514.
27. Wolberg AS,. Thrombin generation and fibrin clot structure. Blood Rev 2007; 21: 131-142.
28. Campbell RA, Overmyer KA, Selzman CH, Sheridan BC, Wolberg AS,. Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability. Blood 2009; 114: 4886-4896.
29. Langdell RD, Wagner RH, Brinkhous KM,. Effect of antihemophilic factor on one-stage clotting tests; a presumptive test for hemophilia and a simple one-stage antihemophilic factor assy procedure. J Lab Clin Med 1953; 41: 637-647.
30. Quick AJ,. The thromboplastin reagent for the determination of prothrombin. Science 1940; 92: 113-114.
31. Beller FK, Koch F, Mammen E,. [Thromboelastographical studies of various disorders of the preliminary and first phases of blood coagulation; a critical note on thromboelastography]. Blut 1956; 2: 112-124.
32. Chitlur M, Sorensen B, Rivard GE, Young G, Ingerslev J, Othman M, Nugent D, Kenet G, Escobar M, Lusher J,. Standardization of thromboelastography: a report from the TEG-ROTEM working group. Haemophilia 2011; 17: 532-537.
33. Ogawa S, Szlam F, Chen EP, Nishimura T, Kim H, Roback JD, Levy JH, Tanaka KA,. A comparative evaluation of rotation thromboelastometry and standard coagulation tests in hemodilution-induced coagulation changes after cardiac surgery. Transfusion 2012; 52: 14-22.
34. Hanke AA, Herold U, Dirkmann D, Tsagakis K, Jakob H, Gorlinger K,. Thromboelastometry based early goal-directed coagulation management reduces blood transfusion requirements, adverse events, and costs in acute type A aortic dissection: a pilot study. Transfus Med Hemother 2012; 39: 121-128.
35. Romlin BS, Wahlander H, Berggren H, Synnergren M, Baghaei F, Nilsson K, Jeppsson A,. Intraoperative thromboelastometry is associated with reduced transfusion prevalence in pediatric cardiac surgery. Anesth Analg 2011; 112: 30-36.
36. Ak K, Isbir CS, Tetik S, Atalan N, Tekeli A, Aljodi M, Civelek A, Arsan S,. Thromboelastography-based transfusion algorithm reduces blood product use after elective CABG: a prospective randomized study. J Card Surg 2009; 24: 404-410.
37. Larsen OH, Fenger-Eriksen C, Christiansen K, Ingerslev J, Sorensen B,. Diagnostic performance and therapeutic consequence of thromboelastometry activated by kaolin versus a panel of specific reagents. Anesthesiology 2011; 115: 294-302.
38. Despotis GJ, Grishaber JE, Goodnough LT,. The effect of an intraoperative treatment algorithm on physicians' transfusion practice in cardiac surgery. Transfusion 1994; 34: 290-296.
39. Afshari A, Wikkelso A, Brok J, Moller AM, Wetterslev J,. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011;(3): CD007871.
40. Tendera M, Syzdol M, Parma Z,. ARISTOTLE RE-LYs on the ROCKET. What's new in stroke prevention in patients with atrial fibrillation? Cardiol J 2012; 19: 4-10.
41. Baglin T, Hillarp A, Tripodi A, Elalamy I, Buller H, Ageno W,. Measuring oral direct inhibitors (ODIs) of thrombin and factor Xa: a recommendation from the Subcommittee on Control of Anticoagulation of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost 2013.
42. Dzik W, Rao A,. Why do physicians request fresh frozen plasma? Transfusion 2004; 44: 1393-1394.
43. Holland LL, Brooks JP,. Toward rational fresh frozen plasma transfusion: the effect of plasma transfusion on coagulation test results. Am J Clin Pathol 2006; 126: 133-139.
44. Matevosyan K, Madden C, Barnett SL, Beshay JE, Rutherford C, Sarode R,. Coagulation factor levels in neurosurgical patients with mild prolongation of prothrombin time: effect on plasma transfusion therapy. J Neurosurg 2011; 114: 3-7.
45. Sarode R, Rawal A, Lee R, Shen YM, Frenkel EP,. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy. Br J Haematol 2006; 132: 604-607.
46. Makris M, Watson HG,. The management of coumarin-induced over-anticoagulation. Annotation. Br J Haematol 2001; 114: 271-280.
47. Chowdhury P, Saayman AG, Paulus U, Findlay GP, Collins PW,. Efficacy of standard dose and 30 mL/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 2004; 125: 69-73.